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Dopamine Responsive Dystonia(DRD) in a 
25 Year Old Lady
Department of Neurology, Chandka Medical College & 
ShaheedMohtarma Benazir Bhutto Medical UniversityHospital, Larkana, Sindh, Pakistan
ABSTRACT
Dopamine responsive dystonia (DRD) is a dystonic syndrome of childhood, usually affecting gait. It presents with 
walking difﬁculties, spasticity or dystonia with a characteristic diurnal variation and MRI brain scan is normal in it. It 
may however develop into Parkinsonism later, which shows dramatic therapeutic response to levodopa. 
A 25 year old lady presented with difﬁculty in walking along with weakness and stiffness of both legs at Neurology 
OPD of Chandka Medical College Hospital,Larkana. After reaching at proper diagnosis of DRD, treatment was 
started. As a result of which, she showed dramatic improvement and was able to return back to her routine life.
C A S E R E P O R T
INTRODUCTION
Dopamine-responsive dystonia (DRD), also known as 
dopa-responsive dystonia or as Segawa disease, is an 
inherited autosomal dominant dystonia typically 
presenting in ﬁrst decade of life (although it may 
present in second to early third decades, or even later). 
It is characterized by diurnal ﬂuctuations, exquisite 
responsiveness to levodopa, and mild Parkinsonian 
features, as well as by striatal dopamine deﬁciency. 
The signs of Parkinsonism are relatively subtle in DRD. 
These signs may include slowness of movement, 
stiffness and resistance to movement (rigidity), 
balance difﬁculties and postural instability. These 
Parkinsonian features often respond well to regular 
doses of levodopa (a synthetic form of the brain 
chemical, dopamine). 
CASE REPORT
A 25 year old lady presented in the outpatient 
department of a tertiary care hospital atLarkana, 
Pakistan with chief complaints of difﬁculty in walking, 
weakness and stiffness of both legs for three years. 
According to the patient's attendant she was in her 
usual state of health three years back when she ﬁrst 
observed difﬁculty in walking which then increased 
slowly & gradually.  After some time owing to unsteady 
gait, she started using acane. But her condition sub-
vitals. Her higher mental functions and cranial 
 nerves were intact.  On motor examination, she had 
normal bulk, tone, power& reﬂexes in both upper 
limbs.Whereas in lower limbs, bulk was normal and 
tone was increased (legs were spastic on touching and 
remained in that position for few seconds & then 
resolved itself). Power was 0/5 in lower limbs. 
However, reﬂexes were normal with ﬂexor planter 
response. Sensory system & Cerebellar system were 
intact and gait was not assessed.Whereas, rest of the 
systemic examination was unremarkable.On slit lamp 
examination, noKayser-Fleischer ring was found and 
fundus examination was normal too.
Her complete blood count, ESR, electrolytes, serum 
calcium level, vitamin D level, liver function test, urine 
detail report were normal, the serum cerulopalsmin& 
24hour urinary copper level were in normal range. Her 
radiographic studies chest x-ray, lumbo-sacral spine, 
CT scan brain were unremarkable, MRI lumbo-sacral 
spine was also normal. 
Sinemet12.5mg/50mg (L-dopa 50 mg + Carbidopa 
12.5 mg) was startedat a dosage of half tablet twice  
worsened further&shebecame completely immobile.  
She, however, had full control of her sphincters.There 
was no other such similar family history. Birth history of 
the patient was unremarkable and developmental 
milestones were normal too with proper immunization 
history.
On Examination, patient was conscious. She was 
oriented to time, place & person with stable vitals and 
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Postural tremor, which is not observed in childhood, 
appears after the third decade. Resting tremor and 
rigidity are absent, and inter limb coordination is 
preserved (even in advanced cases).
Bradykinesia may develop. This is not due to failure of 
initiation and poverty of movement as in Parkinsonism; 
rather, it is due to failure of reciprocal innervation 
resulting from the dystonia.
Muscle tone is increased and deep tendon reﬂexes are 
exaggerated (with ankle clonus). The plantar reﬂex is 
 [ ]
ﬂexor, although striatal toe is common.
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DISCUSSION
Dopamine responsive dystonia (DRD) encompasses a 
group of clinically and genetically heterogeneous 
disorders that typically manifest as limb-onset, 
diurnally ﬂuctuating dystonia and exhibit a robust and 
sustained response to levodopa treatment. Autosomal 
dominant GTP cyclohydrolase 1 deﬁciency, also 
known as Segawa disease, is the most common and 
best-characterized condition that manifests as DRD. 
Dopamine responsive dystonia (DRD) is estimated to 
affect 1 per million people worldwide. Mutations in the 
GCH1 gene are the most common cause of dopa-
responsive dystonia. Less often, mutations in the  TH
or  gene cause this condition.Dopamine is SPR
produced from tyrosine by the action of tyrosine 
hydroxylase (TH , which uses tetrahydrobiopterin 
(BH4) as a cofactor. BH4 is also a cofactor for 
tryptophan and serotonin synthesis, as well as for the 
enzyme nitrous oxide synthetase. The ﬁrst rate-limiting 
step for BH4 synthesis is GCH. The gene for GCH has 
been cloned to 14q 22.1-22.2 and is the gene 
responsible for autosomal-dominant DRD/HPD. 
Mutations in the GCH1 gene are found across the 
entire gene; 99 of the 104 mutant alleles are present in 
a heterozygous state and cause DRD in a dominant 
 [2] 
fashion with reduced penetrance. More than 50% of 
patients with autosomal-dominant inherited DRD have 
 [3, 4, 5, 6, 7]
mutations in the GCH1 gene.
Point mutation in the gene for SR has been detected in 
patients who have autosomal-recessive DRD. SR-
related DRD has been shown to be similar to, yet 
 [8]
somewhat more severe than, TH-deﬁcient DRD.
Despite advances in the understanding of DRD, 
genetic testing is not deﬁnitive. Thirty percent to 40% of 
patients with DRD do not show the common mutations.
Girls are affected more than boys with ratio of 2 or 3:1. 
The most common presenting symptom of dopamine-
responsive dystonia (DRD) is a gait disturbance. 
These patients may be misdiagnosed as having 
cerebral palsy. Typically, the dystonia starts in 1 lower 
limb (with evening exacerbation), resulting in a tiptoe 
(equinus) walking pattern. Early in the disease course, 
patients are symptom free in the morning. Diurnal 
aggravation of symptoms depends more on the 
number of waking hours than on physical activity. The 
disease progresses markedly in the ﬁrst 15 years, with 
postural dystonia progressing to all 4 limbs (even in the 
morning) by the end of the second decade. 
Progression slows in the third decade and plateaus 
 [ ]
thereafter.  The dystonia is variable in severity, 
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depending on the duration of disease prior to 
treatment. Gait disturbance is characterized by leg 
stiffness and a tendency to walk in an equinus posture. 
The great toe is dorsiﬂexed. Gait tends to worsen later 
in the day. With increasing age and without treatment, 
dystonia spreads to involve the trunk and all 4 
extremities.  
DIAGNOSIS
The diagnosis of DRD is not made by one deﬁnitive 
test, but by a series of clinical observations and 
speciﬁc biochemical assessments. Deﬁning the 
exact cause may not be possible.
A therapeutic trial with levodopa remains the most 
practical initial approach to diagnosis. Even an 
adverse reaction may help illuminate details about the 
cause and warrant additional tests, and not all DRD 
pat ients respond to levodopa immediately. 
Furthermore, not all individuals who are carriers will 
exhibit symptoms. A detailed family history is an 
important element of diagnosis.
Obtaining a cerebrospinal ﬂuid sample (via lumbar 
puncture) is an important component of diagnosing 
DRD. This may be the most straightforward way to 
obtain a preliminary diagnosis and distinguish among 
possible metabolic conditions. There remains a 
chance that the cerebrospinal test will not provide a 
deﬁnitive diagnosis. It is crucial that the patient stop 
taking levodopa at least a week before the 
cerebrospinal ﬂuid collection.
Speciﬁc metabolic defects may be detected by an oral 
phenylalanine loading test, but the test is not 100% 
sensitive and the scope is limited. False negatives may 
occur with this test, detecting only about 80% of cases 
of DRD. Similarly, there are tests for very speciﬁc 
metabolic conditions that do not address the entire 
scope of possible deﬁciencies.
DRD must be distinguished from other disorders with 
similar symptoms including cerebral palsy, early-onset 
generalized dystonia, spastic paraplegia, and 
disorders which cause childhood-onset parkinsonism.
Patients and family members should understand that 
diagnosing DRD can be challenging, but that there are 
steps toward differentiating among the various types.
TREATMENT
Symptoms of DRD can usually be treated effectively 
with a drug called levodopa, and most often a 
combination of levodopa and carbidopa. In many 
cases, full physical functionality including walking, 
running, speaking, and writing is restored or 
preserved.
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